Novavax Inc (NVAX)
9.35
-0.26
(-2.71%)
USD |
NASDAQ |
Nov 01, 16:00
9.42
+0.07
(+0.75%)
After-Hours: 20:00
Novavax Net Income (Quarterly): 162.38M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 162.38M |
| March 31, 2024 | -147.55M |
| December 31, 2023 | -178.39M |
| September 30, 2023 | -130.78M |
| June 30, 2023 | 58.01M |
| March 31, 2023 | -293.90M |
| December 31, 2022 | -182.25M |
| September 30, 2022 | -168.61M |
| June 30, 2022 | -510.48M |
| March 31, 2022 | 203.41M |
| December 31, 2021 | -846.28M |
| September 30, 2021 | -322.43M |
| June 30, 2021 | -352.32M |
| March 31, 2021 | -222.72M |
| December 31, 2020 | -177.56M |
| September 30, 2020 | -197.31M |
| June 30, 2020 | -17.52M |
| March 31, 2020 | -25.86M |
| December 31, 2019 | -31.83M |
| September 30, 2019 | -18.04M |
| June 30, 2019 | -39.60M |
| March 31, 2019 | -43.22M |
| December 31, 2018 | -49.33M |
| September 30, 2018 | -44.57M |
| June 30, 2018 | -44.49M |
| Date | Value |
|---|---|
| March 31, 2018 | -46.35M |
| December 31, 2017 | -50.84M |
| September 30, 2017 | -44.61M |
| June 30, 2017 | -44.46M |
| March 31, 2017 | -43.85M |
| December 31, 2016 | -57.11M |
| September 30, 2016 | -66.25M |
| June 30, 2016 | -79.35M |
| March 31, 2016 | -77.25M |
| December 31, 2015 | -78.81M |
| September 30, 2015 | -33.12M |
| June 30, 2015 | -20.64M |
| March 31, 2015 | -24.37M |
| December 31, 2014 | -31.55M |
| September 30, 2014 | -19.73M |
| June 30, 2014 | -17.86M |
| March 31, 2014 | -13.81M |
| December 31, 2013 | -14.05M |
| September 30, 2013 | -15.30M |
| June 30, 2013 | -12.63M |
| March 31, 2013 | -9.996M |
| December 31, 2012 | -8.035M |
| September 30, 2012 | -7.217M |
| June 30, 2012 | -5.92M |
| March 31, 2012 | -7.336M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-846.28M
Minimum
Dec 2021
203.41M
Maximum
Mar 2022
-178.00M
Average
-177.56M
Median
Dec 2020
Net Income (Quarterly) Benchmarks
| Pfizer Inc | 4.465B |
| Moderna Inc | -1.279B |
| BioCryst Pharmaceuticals Inc | -12.67M |
| Eli Lilly and Co | 970.30M |
| AIM ImmunoTech Inc | -1.836M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 415.48M |
| Total Expenses (Quarterly) | 254.49M |
| EPS Diluted (Quarterly) | 0.99 |
| Enterprise Value | 616.13M |
| Gross Profit Margin (Quarterly) | 88.87% |
| Profit Margin (Quarterly) | 39.08% |
| Earnings Yield | -29.84% |
| Normalized Earnings Yield | -29.84 |